Literature DB >> 15225175

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

J S Labus1, R Bolus, L Chang, I Wiklund, J Naesdal, E A Mayer, B D Naliboff.   

Abstract

BACKGROUND: Anxiety related to gastrointestinal sensations, symptoms or the contexts in which these may occur is thought to play a significant role in the pathophysiology as well as in the health outcomes of patients with irritable bowel syndrome. AIM: To develop a valid and reliable psychometric instrument that measures gastrointestinal symptom-specific anxiety.
METHODS: External and internal expert panels as well as a patient focus group evaluated a large pool of potential item stems gathered from the psychological and gastrointestinal literature. Potential scale items were then administered to 96 patients diagnosed with irritable bowel syndrome along with a set of validating questionnaires. Final item selection was based upon rigorous empirical criteria and the psychometric properties of the final scale were examined.
RESULTS: A final unidimensional 15-item scale, the Visceral Sensitivity Index, demonstrated excellent reliability as well as good content, convergent, divergent and predictive validity.
CONCLUSIONS: The findings suggest that the Visceral Sensitivity Index is a reliable, valid measure of gastrointestinal symptom-specific anxiety that may be useful for clinical assessment, treatment outcome studies, and mechanistic studies of the role of symptom-related anxiety in patients with irritable bowel syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15225175     DOI: 10.1111/j.1365-2036.2004.02007.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  112 in total

1.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

2.  Association between early adverse life events and irritable bowel syndrome.

Authors:  Kara Bradford; Wendy Shih; Elizabeth J Videlock; Angela P Presson; Bruce D Naliboff; Emeran A Mayer; Lin Chang
Journal:  Clin Gastroenterol Hepatol       Date:  2011-12-16       Impact factor: 11.382

3.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

4.  Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.

Authors:  A M Su; W Shih; A P Presson; L Chang
Journal:  Neurogastroenterol Motil       Date:  2013-08-29       Impact factor: 3.598

5.  The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.

Authors:  Lisa A Kilpatrick; Jennifer S Labus; Kristen Coveleskie; Christian Hammer; Gudrun Rappold; Kirsten Tillisch; Joshua A Bueller; Brandall Suyenobu; Johana M Jarcho; Jim A McRoberts; Beate Niesler; Emeran A Mayer
Journal:  Gastroenterology       Date:  2011-03-21       Impact factor: 22.682

Review 6.  The brain-gut axis in abdominal pain syndromes.

Authors:  Emeran A Mayer; Kirsten Tillisch
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 7.  Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.

Authors:  Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

8.  Measuring acceptance in irritable bowel syndrome: preliminary validation of an adapted scale and construct utility.

Authors:  Nuno Bravo Ferreira; Maria P Eugenicos; Paul Graham Morris; David T Gillanders
Journal:  Qual Life Res       Date:  2012-10-25       Impact factor: 4.147

9.  GERD symptoms in the general population: prevalence and severity versus care-seeking patients.

Authors:  Erica Cohen; Roger Bolus; Dinesh Khanna; Ron D Hays; Lin Chang; Gil Y Melmed; Puja Khanna; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

10.  The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

Authors:  Jeffrey M Lackner; Laurie Keefer; James Jaccard; Rebecca Firth; Darren Brenner; Jason Bratten; Laura J Dunlap; Changxing Ma; Mark Byroads
Journal:  Contemp Clin Trials       Date:  2012-07-28       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.